Current location:style >>
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
style441People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b ...
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Culture Compass news portal”。http://mauritius.downmusic.org/news-84d599395.html
Related articles
California congressman urges closer consultation with tribes on offshore wind
styleA congressman who represents California’s north coast has sent a letter to federal regulators asking ...
【style】
Read moreChina to launch Chang'e
styleWENCHANG, Hainan, May 3 (Xinhua) -- The Chang'e-6 lunar probe is scheduled to be launched between 5 ...
【style】
Read moreInside Kevin Spacey's 'eight
styleFallen Hollywood star Kevin Spacey once declared his love for girlfriend Dianne Dreyer from the stag ...
【style】
Read more
Popular articles
- Shohei Ohtani's first walk
- Smart tourism development conference held in Nanjing
- Nets edge Raptors to snap six
- Chloe Sims, 42, and Lionel Richie's son Miles, 29, 'SPLIT!' Couple call time on their whirlwind four
- Not so Cool Britannia! Noel Gallagher gives damning verdict on Keir Starmer
- Investing in China is a superior option for multinationals
Latest articles
Lynn Williams breaks NWSL goal
Olympic champion Ye qualifies for Paris 2024
Inside the Met Gala: A fairytale forest, woodland creatures, and some starstruck first
China Cruise Shipping Conference opens in Shenzhen
Analysis: Larson enters conversation with Verstappen as best drivers in the world
China to launch Chang'e
LINKS
- Hundreds of firefighters battle Western Australia wildfire
- Ministry of Ethnic Communities, set up to 'heal wounds' of 15 March, faces job cuts
- Proposal unveiled for new facility combining Nelson's library, civic centre, community hub
- Blizzard strikes North America, cancelling flights and disrupting presidential campaign
- Tame Iti brings Haki Ātea to Waitangi
- Death penalty for artist behind Kyoto anime fire, which killed 36
- China and India hold talks over Ladakh border standoff
- Easter weather: Chilly Good Friday forecast as southerly winds sweep New Zealand
- No thanks to traditional meals, say Gen Z
- ‘Easter is a time to remember . . . to remember, amid all the distractions of life’